The predictive capacity of various laboratoryindicators for CSA-AKI were assessed, including tumor necrosisfactor-α (TNF-α), interleukin 2, interleukin 6, and neutrophilgelatinase-associated lipocalin (NGAL). The gene discussed is LCN2; the disease is chromosome-type aberration frequency.